MiMedx Group, Inc

MDXG Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of MDXG by members of U.S. Congress

Politician Type Traded
Tom Malinowski House / D Sale $15,001 - $50,000 May 30, 2019
MDXG Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MDXG Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDXG Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in MDXG holdings by institutional investors

Insider Trading

Quarterly net insider trading by MDXG's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $30,000 Nov 06, 2025 Issue: Medicare/Medicaid
  • $20,000 Oct 17, 2025 Issue: Medicare/Medicaid
  • $30,000 Jul 25, 2025 Issue: Medicare/Medicaid
  • $20,000 Jul 09, 2025 Issue: Medicare/Medicaid
  • $30,000 May 06, 2025 Issue: Medicare/Medicaid
  • $20,000 Apr 16, 2025 Issue: Medicare/Medicaid
  • $30,000 Feb 05, 2025 Issue: Medicare/Medicaid
  • $20,000 Jan 10, 2025 Issue: Medicare/Medicaid
  • $30,000 Nov 08, 2024 Issue: Medicare/Medicaid
  • $20,000 Oct 18, 2024 Issue: Medicare/Medicaid
  • $30,000 Aug 06, 2024 Issue: Medicare/Medicaid
  • $20,000 Jul 19, 2024 Issue: Medicare/Medicaid
  • $20,000 Apr 17, 2024 Issue: Medicare/Medicaid
  • $20,000 Jan 22, 2024 Issue: Medicare/Medicaid
  • $20,000 Oct 18, 2023 Issue: Medicare/Medicaid
  • $50,000 Jul 18, 2023 Issue: Medicare/Medicaid
  • $50,000 Jan 18, 2023 Issue: Medicare/Medicaid
  • $50,000 Oct 19, 2022 Issue: Medicare/Medicaid
  • $50,000 Jul 19, 2022 Issue: Medicare/Medicaid
  • $30,000 Apr 19, 2022 Issue: Medicare/Medicaid
  • $30,000 Jan 19, 2022 Issue: Medicare/Medicaid
  • $30,000 Oct 19, 2021 Issue: Medicare/Medicaid
  • $30,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $35,000 Apr 20, 2021 Issue: Medicare/Medicaid
  • $20,000 Jan 20, 2021 Issue: Medicare/Medicaid
Corporate Lobbying

MDXG Estimated quarterly lobbying spending

Revenue Breakdown

MDXG Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MDXG Income Statement
MDXG Balance Sheet
MDXG Cash Flow
U.S. Patents

New MDXG patent grants

  • Patent Title: Placental tissue grafts May. 01, 2018
  • Patent Title: Tissue grafts composed of micronized placental tissue and methods of making and using the same Apr. 17, 2018
  • Patent Title: Methods of making implantable collagen fiber Jan. 23, 2018
  • Patent Title: Non-surgical, localized delivery of compositions for placental growth factors Nov. 28, 2017
  • Patent Title: Medical constructs including tubes and collagen fibers Oct. 31, 2017
  • Patent Title: Placental tissue grafts and improved methods of preparing and using the same Oct. 17, 2017
  • Patent Title: Synthetic collagen threads for cosmetic uses including skin wrinkle treatments and associated methods Jul. 04, 2017
  • Patent Title: Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same Jun. 27, 2017
  • Patent Title: Biostaples suitable for wrist, hand and other ligament replacements or repairs Jun. 20, 2017
  • Patent Title: Methods for treating cardiac conditions May. 30, 2017
  • Patent Title: Non-surgical, localized delivery of compositions for placental growth factors May. 23, 2017
  • Patent Title: Collagen fiber ribbons with integrated fixation sutures and methods of making the same May. 02, 2017
  • Patent Title: Methods of using compressible tubes for placing implants Apr. 04, 2017
  • Patent Title: Placental tissue grafts and methods of preparing and using the same Feb. 21, 2017
  • Patent Title: Dehydration device and methods for drying biological materials Jan. 31, 2017
  • Patent Title: Placental tissue grafts and methods of preparing and using the same Jan. 03, 2017
  • Patent Title: Placental tissue grafts Oct. 11, 2016
  • Patent Title: Cross-linked dehydrated placental tissue grafts and methods for making and using the same Oct. 11, 2016
  • Patent Title: Polymer chelator conjugates Sep. 20, 2016
  • Patent Title: Placental tissue grafts Sep. 06, 2016
  • Patent Title: Placental tissue grafts Aug. 16, 2016
  • Patent Title: Placental tissue grafts Mar. 01, 2016
  • Patent Title: Placental tissue grafts Mar. 01, 2016
  • Patent Title: Placental tissue grafts Feb. 23, 2016
  • Patent Title: Placental tissue grafts Feb. 23, 2016
  • Patent Title: Medical constructs of twisted lengths of collagen fibers and methods of making same Dec. 22, 2015
  • Patent Title: Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same Nov. 17, 2015
  • Patent Title: Compositions and methods for recruiting and localizing stem cells Nov. 10, 2015
  • Patent Title: Methods of making collagen fiber medical constructs and related medical constructs, including tubes Nov. 10, 2015
  • Patent Title: Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent Oct. 13, 2015
  • Patent Title: Biocomposite medical constructs including artificial tissues, vessels and patches Sep. 08, 2015
  • Patent Title: Placental tissue grafts and methods of preparing and using the same Jul. 21, 2015
  • Patent Title: Methods of making collagen fiber medical constructs and related medical constructs, including nerve guides and patches Jul. 14, 2015
  • Patent Title: Compressible tubes for placing implants and related medical kits and methods of using same Apr. 14, 2015
  • Patent Title: Implantable collagen devices and related methods and systems of making same Mar. 24, 2015
  • Patent Title: Cross-linked collagen comprising metallic anticancer agents Feb. 03, 2015
  • Patent Title: Cross-linked collagen comprising an antifungal agent Jan. 27, 2015
  • Patent Title: Placental tissue grafts Jan. 13, 2015
  • Patent Title: Dehydration device and methods for drying biological materials Dec. 09, 2014
  • Patent Title: Placental tissue grafts Apr. 29, 2014
  • Patent Title: Placental tissue grafts Apr. 29, 2014
  • Patent Title: Placental tissue grafts Apr. 22, 2014
  • Patent Title: Placental tissue grafts Apr. 22, 2014
  • Patent Title: Placental tissue grafts Feb. 04, 2014
  • Patent Title: Placental graft Jan. 07, 2014
  • Patent Title: Spinal disc implants with flexible keels and methods of fabricating implants Dec. 10, 2013
  • Patent Title: Methods for determining the orientation of a tissue graft Dec. 03, 2013
  • Patent Title: Methods for forming implants with selectively exposed mesh for fixation and related implants Jul. 02, 2013
  • Patent Title: Method for applying a label to a placental tissue graft Jun. 11, 2013
  • Patent Title: Placental tissue grafts Jun. 11, 2013
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to MDXG from public contracts

MDXG News

Recent insights relating to MDXG

CNBC Recommendations

Recent picks made for MDXG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDXG

MDXG Analyst Ratings

MDXG Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MDXG Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MDXG stock a Buy, Sell, or Hold?

  • What is the price target for $MDXG stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MDXG Top Shareholders
Shareholder
Shares Held
MDXG Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MDXG stock?

  • Who owns the most shares of $MDXG stock?

  • What funds own $MDXG stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDXG Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDXG Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MDXG

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

  • Address Marietta, GA
  • Market Cap 1.0 billion
  • Employees 837
  • Industrial Classification Surgical & Medical Instruments & Apparatus
Back To Top